Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
17,039,592
-
Share change
-
+381,157
-
Total reported value
-
$375,355,107
-
Price per share
-
$22.11
-
Number of holders
-
46
-
Value change
-
+$8,764,813
-
Number of buys
-
26
-
Number of sells
-
20
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q1 2018
As of 31 Mar 2018,
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,039,592 shares.
The largest 10 holders included
Cormorant Asset Management, LP, Sectoral Asset Management Inc, Vivo Capital, LLC, Hillhouse Capital Management, Ltd., BlackRock Inc., EcoR1 Capital, LLC, FMR LLC, Sofinnova Ventures Inc, RA CAPITAL MANAGEMENT, LLC, and Clough Capital Partners L P.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.